Concepedia

Author

Magali Rebucci-Peixoto

Centre Georges François Leclerc

Also Known As

Benjamin Cuinet, M. Rebucci-Peixoto, Magali Rebucci-Peixoto

13

Publications

90

Citations

4

H-Index

0

Concepts

All Affiliations

Centre Georges François LeclercInsermCentre Hospitalier Universitaire de BesançonHôpital Paris Saint-Joseph
MR

About

Magali Rebucci-Peixoto is an author at Centre Georges François Leclerc.

Magali Rebucci-Peixoto

×

3

Publications

74

Citations

3

H-Index

YearCitations

Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial

Stéfano Kim, Bruno Buecher, Thierry André,

BMC Cancer

2020

27

A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 TH1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study

Magali Rebucci-Peixoto, Angélique Vienot, Olivier Adotévi,

Frontiers in Oncology

2022

26

Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO – PRODIGE 82)

Angélique Vienot, Marion Jacquin, Magali Rebucci-Peixoto,

BMC Cancer

2023

21

Page 1